The study is the first prospective global real-world study of a biologic treatment in patients with severe eosinophilic asthma.
News
Suliqua launches in UK
The approval is based on two phase III studies, LixiLan-O and LixiLan-L.
Lenvima, Keytruda combo shows anti-tumour activity
Following the positive results of the trial, the companies have announced that the LEAP-001 Phase III study is now underway.
Gov’t pledges overhaul of cancer screening
Hospitals to get upgraded machines under the plans
Entyvio beats Humira in head-to-head ulcerative colitis trial
Results offer new insight to support treatment decisions, Takeda says
RSPH calls for swift action on declining child vaccine coverage
The government must follow through with its commitment to deliver a comprehensive strategy this Autumn, to address the gaps in vaccination uptake, the Society says
Pfizer UK removes sales incentives for anti-infectives
The move comes under the firm’s commitment to fight antimicrobial resistance
Industry shoots down Labour’s plans to tackle ‘extortionate’ drug prices
Labour intends to create state-owned generic drugs company
Positive PhIII data for Jazz sleep disorder drug
JZP-258 achieved primary and key secondary endpoints showing significant differences in weekly number of cataplexy attacks and Epworth Sleepiness Scale scores compared to placebo
NICE backs womb op for babies with spina bifida
Procedure carried out on unborn babies with spina bifida could improve their neurodevelopment
Novartis’ Aimovig unlikely to be NHS funded for migraine
NICE has published final draft guidelines rejecting the drug in this setting
A category to cover all areas within medical affairs in MSEA 2019
The categories in the Medical & Scientific Excellence Awards have been expertly designed to accurately reflect the current medical affairs environment.
European Commission grants orphan status to nirogacestat
The drug is being developed for the treatment of soft tissue sarcoma
CR UK kicks off entrepreneurship initiative
The programme strives to promote the development of new business ventures within academia
University opens new earlier diagnosis institute
The Sir James Mackenzie Institute for Early Diagnosis Information is an international collaboration striving to secure earlier disease detection
